Bipartisan Health Care Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The Bipartisan Health Care Act (S.891) extends dozens of expiring federal health programs and makes improvements to healthcare delivery across Medicaid, Medicare, public health, substance use disorder treatment, and pandemic preparedness. It is an omnibus health bill that reauthorizes funding, extends temporary flexibilities (particularly around telehealth), and introduces new program integrity requirements to reduce fraud and waste.
Who Benefits and How
Healthcare Providers benefit from expanded telehealth flexibilities extended through 2026, streamlined multi-state Medicaid enrollment for treating out-of-state patients, continued payment add-ons for ambulance services and low-volume hospitals, and extended incentive payments for participating in alternative payment models.
Medicare Beneficiaries gain access to new multi-cancer early detection screening tests, continued telehealth access from their homes, improved pharmacy access through "any willing provider" requirements, and lower copays for low-income seniors on Part D prescription drugs.
Medicaid Beneficiaries benefit from expanded home and community-based services (HCBS) with new waiting list transparency, removal of age restrictions for working adults with disabilities, and portable coverage for military families who relocate between states.
Community Health Centers and Public Health Programs receive extended funding through 2026, including National Health Service Corps, special diabetes programs, and 9/11 responder health programs with inflation-adjusted funding through 2040.
Who Bears the Burden and How
State Medicaid Agencies must implement new program integrity requirements including address verification for enrollees, deceased individual checks quarterly, and detailed reporting on maternity care costs and HCBS waiting lists.
Pharmacy Benefit Managers (PBMs) face new restrictions on "spread pricing" (the practice of charging health plans more than they reimburse pharmacies) and must disclose compensation arrangements, with potential contract termination for violations.
Medicare Advantage Plans must maintain accurate, verified provider directories with quarterly updates, facing sanctions for non-compliance with directory accuracy standards.
Taxpayers fund the appropriations for extended programs, though some provisions include offsetting mechanisms through the Medicare Improvement Fund and sequestration adjustments.
Key Provisions
- Telehealth extensions: Continues Medicare telehealth flexibilities through December 2026, allowing patients to receive services at home and from audio-only platforms
- Multi-cancer screening: Creates new Medicare coverage for blood-based tests that can detect multiple cancers simultaneously
- PBM accountability: Requires transparency in pharmacy benefit manager contracts and prohibits abusive spread pricing in Medicaid
- Hospital payment protections: Extends increased payments for low-volume hospitals, Medicare-dependent hospitals, and disproportionate share hospitals serving low-income patients
- Substance use treatment: Reauthorizes the SUPPORT Act programs for opioid and substance use disorder treatment, including medication-assisted treatment flexibilities
- Pandemic preparedness: Reauthorizes BARDA, the Strategic National Stockpile, and public health emergency response authorities through 2030
- Pharmacy access: Requires Medicare Part D plans to accept any pharmacy willing to meet standard contract terms
- Military family coverage: Ensures Medicaid coverage portability for military families who relocate due to active duty assignments
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Extends expiring health provisions and improves health care delivery across Medicaid, Medicare, public health, substance use disorder treatment, and pandemic preparedness programs.
Who Benefits
- Healthcare providers (expanded telehealth, simplified enrollment, payment extensions)
- Medicare beneficiaries (multi-cancer screening coverage, telehealth access, Part D improvements)
- Medicaid beneficiaries (HCBS expansion, military family coverage portability)
Who Bears Costs
- State Medicaid agencies (new reporting requirements, address verification, deceased enrollee checks)
- Pharmacy Benefit Managers (spread pricing restrictions, transparency requirements)
- Medicare Advantage plans (provider directory accuracy requirements)
Key Policy Areas
Healthcare, Medicaid, Medicare, Public Health, Substance Use Disorder Treatment, Pandemic Preparedness, Maternal Health, Telehealth
Primary Purpose
Extends expiring health provisions and improves health care delivery across Medicaid, Medicare, public health, substance use disorder treatment, and pandemic preparedness programs.
Policy Domains
Legislative Strategy
"Extend expiring health programs, improve program integrity, expand telehealth access, and reauthorize substance use and pandemic preparedness programs."
Identified Gains
- Healthcare providers (expanded telehealth, simplified enrollment, payment extensions)
- Medicare beneficiaries (multi-cancer screening coverage, telehealth access, Part D improvements)
- Medicaid beneficiaries (HCBS expansion, military family coverage portability)
- Hospitals (rural hospital payment extensions, disproportionate share hospital payments)
- Pharmacies (accurate payments, spread pricing protections)
- Substance use disorder treatment providers (program reauthorizations, workforce funding)
- Community health centers (funding extensions)
- Public health infrastructure (pandemic preparedness funding)
Identified Costs
- State Medicaid agencies (new reporting requirements, address verification, deceased enrollee checks)
- Pharmacy Benefit Managers (spread pricing restrictions, transparency requirements)
- Medicare Advantage plans (provider directory accuracy requirements)
- Managed care entities (address verification transmission requirements)
- Taxpayers (appropriations for various programs)
Sponsors
Ron Wyden
D-OR | Primary Sponsor
Legislative Progress
In CommitteeMr. Wyden (for himself and Mr. Sanders) introduced the following …
Read twice and referred to the Committee on Finance.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Child trauma treatment centers, Durable medical equipment suppliers, FASD research and treatment providers
Positive-direction: Child trauma treatment centers, FASD research and treatment providers, Family health information centers, Hospitals and healthcare coalitions, Independent pharmacies, Mental health providers, National Health Service Corps providers, Out-of-state healthcare providers, Pharmacies, Quality measure endorsement organizations, Safety-net hospitals serving uninsured patients, State Health Insurance Assistance Programs (SHIPs), Telehealth providers
Negative-direction: Durable medical equipment suppliers, Hospitals with off-campus outpatient departments, Prescribers of controlled substances, Suicide prevention hotline operators
DEA enforcement, Medicare program administration, Public health agencies
State Medicaid programs faces effects in multiple directions
Positive-direction: DEA enforcement, Medicare program administration, Public health agencies, State Medicaid and CHIP programs, State and local health departments, State health departments, States with HCBS waiver programs
Negative-direction: State Medicaid agencies, State governments
9/11 responders and survivors, Low-income Medicare Part D beneficiaries, Medicaid beneficiaries needing HCBS
Substance use disorder treatment providers, Substance use treatment providers
Medical countermeasure manufacturers, Pharmaceutical manufacturers of antivirals, Rare disease drug developers
Abstinence education providers, Mental health training programs, Teen pregnancy prevention program providers
Prematurity research institutions, Public health laboratories, Research institutions with biocontainment facilities
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_state"
- → State Medicaid agencies
- "the_secretary"
- → Secretary of Health and Human Services
- "cms"
- → Centers for Medicare & Medicaid Services
- "the_secretary"
- → Secretary of Health and Human Services
- "the_secretary"
- → Secretary of Health and Human Services
- "the_secretary"
- → Secretary of Health and Human Services
- "dea"
- → Drug Enforcement Administration
- "samhsa"
- → Substance Abuse and Mental Health Services Administration
- "the_secretary"
- → Secretary of Health and Human Services
- "cdc"
- → Centers for Disease Control and Prevention
- "aspr"
- → Assistant Secretary for Preparedness and Response
- "barda"
- → Biomedical Advanced Research and Development Authority
- "the_secretary"
- → Secretary of Health and Human Services
- "the_secretary"
- → Secretary of Health and Human Services
Note: 'The Secretary' refers to the Secretary of Health and Human Services throughout the bill, with no conflicts between titles.
Key Definitions
Terms defined in this bill
A provider located in another state that has been screened and enrolled in Medicare or another state's Medicaid program with limited fraud risk determination.
An individual enrolled under State Medicaid plan who is a member of the Armed Forces (or dependent) relocated to another State by reason of active duty service.
A screening test for the purpose of detecting cancer that is intended to detect signals for 2 or more cancers simultaneously with a single assay.
A list maintained by a State of individuals requesting HCBS for whom the State has not yet completed an eligibility assessment due to service limits.
An individual under 21 years of age who is enrolled under the State Medicaid plan.
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology